The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development.

Developments in biologicals

Volumn 112, Issue , 2003, Pages 81-97

  Patten, P A ^a   Schellekens, H ^a  

^a MAXYGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; DRUG DESIGN; GENETICS; HUMAN; IMMUNOLOGY; PHARMACEUTICS;

ANIMALS; BIOPHARMACEUTICS; DRUG DESIGN; HUMANS; RECOMBINANT PROTEINS;

EID: 0042526640     PISSN: 14246074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)